TEAS RF New Application

TREATING ONE VENTRICLE AT A TIME

Mezzion Pharma Co., Ltd.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88693752
Filing Date: 11/15/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88693752
MARK INFORMATION
*MARK TREATING ONE VENTRICLE AT A TIME
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TREATING ONE VENTRICLE AT A TIME
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Mezzion Pharma Co., Ltd.
INTERNAL ADDRESS 3F, C&H Bldg 35
*STREET Teheran-ro 87-Gil, Gangnam-Gu
*CITY Seoul
*COUNTRY Korea, South
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
06167
LEGAL ENTITY INFORMATION
TYPE limited company (ltd.)
STATE/COUNTRY WHERE LEGALLY ORGANIZED Korea, South
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 041 
*IDENTIFICATION Educational services, namely seminars, blogs, websites and other materials in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Medical and pharmaceutical research and development services; scientific and technological research services related thereto; medical testing and screening services; clinical trials.
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Howard M. Gitten
ATTORNEY DOCKET NUMBER 40836-6300US
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Lewis Brisbois Bisgaard & Smith
STREET 110 SE 6th Street, Suite 2600
CITY Ft. Lauderdale
STATE Florida
COUNTRY United States
ZIP/POSTAL CODE 33301
PHONE 954-939-3368
FAX 954-728-1280
EMAIL ADDRESS howard.gitten@lewisbrisbois.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Jill Anderfuren, Stacy Schwartz, Michael Greenberg
CORRESPONDENCE INFORMATION
NAME Howard M. Gitten
FIRM NAME Lewis Brisbois Bisgaard & Smith
STREET 550 W. Adams Street, Suite 300
CITY Chicago
STATE Illinois
COUNTRY United States
ZIP/POSTAL CODE 60661
PHONE 312-345-1718
FAX 312-345-1778
*EMAIL ADDRESS USdocket@lewisbrisbois.com; howard.gitten@lewisbrisbois.com; dedi.whitman@lewisbrisbois.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 550
*TOTAL FEE PAID 550
SIGNATURE INFORMATION
SIGNATURE /Howard M. Gitten/
SIGNATORY'S NAME Howard M. Gitten
SIGNATORY'S POSITION Attorney of record, Florida bar member
SIGNATORY'S PHONE NUMBER 954 939 3368
DATE SIGNED 11/15/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88693752
Filing Date: 11/15/2019

To the Commissioner for Trademarks:

MARK: TREATING ONE VENTRICLE AT A TIME (Standard Characters, see mark)
The literal element of the mark consists of TREATING ONE VENTRICLE AT A TIME. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Mezzion Pharma Co., Ltd., a limited company (ltd.) legally organized under the laws of Korea, South, having an address of
      3F, C&H Bldg 35
      Teheran-ro 87-Gil, Gangnam-Gu
      Seoul 06167
      Korea, South

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 041:  Educational services, namely seminars, blogs, websites and other materials in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Medical and pharmaceutical research and development services; scientific and technological research services related thereto; medical testing and screening services; clinical trials.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The applicant hereby appoints Howard M. Gitten. Other appointed attorneys are Jill Anderfuren, Stacy Schwartz, Michael Greenberg. Howard M. Gitten of Lewis Brisbois Bisgaard & Smith, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      110 SE 6th Street, Suite 2600
      Ft. Lauderdale, Florida 33301
      United States
      954-939-3368(phone)
      954-728-1280(fax)
      howard.gitten@lewisbrisbois.com (authorized).
The attorney docket/reference number is 40836-6300US.
Howard M. Gitten submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Howard M. Gitten
      Lewis Brisbois Bisgaard & Smith
      550 W. Adams Street, Suite 300
      Chicago, Illinois 60661
      312-345-1718(phone)
      312-345-1778(fax)
      USdocket@lewisbrisbois.com; howard.gitten@lewisbrisbois.com; dedi.whitman@lewisbrisbois.com (authorized).

Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Howard M. Gitten/   Date: 11/15/2019
Signatory's Name: Howard M. Gitten
Signatory's Position: Attorney of record, Florida bar member
Payment Sale Number: 88693752
Payment Accounting Date: 11/15/2019

Serial Number: 88693752
Internet Transmission Date: Fri Nov 15 10:51:34 EST 2019
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20191115105134459
752-88693752-7006577314d22e3e50d39cbb1df
0415d5def6016597494b16d2386c97af91a96-CC
-51337576-20191115092009526549

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed